Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
US7642258 | ABBVIE INC | Combination of brimonidine and timolol for topical ophthalmic use |
Apr, 2022
(1 year, 11 months ago) | |
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7320976 | ABBVIE INC | Combination of brimonidine and timolol for topical ophthalmic use |
Apr, 2022
(1 year, 11 months ago) | |
US8133890 | ABBVIE INC | Combination of brimonidine and timolol for topical ophthalmic use |
Apr, 2022
(1 year, 11 months ago) | |
US9770453 | ABBVIE INC | Combination of brimonidine and timolol for topical ophthalmic use |
Apr, 2022
(1 year, 11 months ago) | |
US9907801 | ABBVIE INC | Combination of brimonidine and timolol for topical ophthalmic use |
Apr, 2022
(1 year, 11 months ago) | |
US8354409 | ABBVIE INC | Combination of brimonidine and timolol for topical ophthalmic use |
Apr, 2022
(1 year, 11 months ago) | |
US8748425 | ABBVIE INC | Combination of brimonidine and timolol for topical ophthalmic use |
Apr, 2022
(1 year, 11 months ago) | |
US9907802 | ABBVIE INC | Combination of brimonidine and timolol for topical ophthalmic use |
Apr, 2022
(1 year, 11 months ago) | |
US9474751 | ABBVIE INC | Combination of brimonidine and timolol for topical ophthalmic use |
Apr, 2022
(1 year, 11 months ago) | |
US7030149 | ABBVIE INC | Combination of brimonidine timolol for topical ophthalmic use |
Apr, 2022
(1 year, 11 months ago) | |
US7323463 | ABBVIE INC | Combination of brimonidine and timolol for topical ophthalmic use |
Jan, 2023
(1 year, 2 months ago) |
Market Authorisation Date: 30 October, 2007
Treatment: Reduction of elevated intraocular pressure (iop) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled iop. dose is one drop of ...
Dosage: SOLUTION/DROPS;OPHTHALMIC